Hypertrophic cardiomyopathy trials in China

In China 19 Also abroad 88

19 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
The Application of T1 Mapping in Real-World
Where
Beijing
People
2,000
Run by
Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07354646
No phaseTaking people
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Where
Beijing, Changchun, Chengdu, Dalian, Guangzhou, Hangzhou, Harbin, Jiazhuang, Jinan, Shanghai, Suzhou, Xi'an, Zhengzhou
Age
18 years and over
People
500
Run by
Bristol-Myers Squibb
See details and how to joinNCT07361289
No phaseNot yet taking people in China
Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy
Where
Shanghai
Age
18 years and over
People
800
Run by
Bristol-Myers Squibb
See details and how to joinNCT07846059
No phaseTaking people
A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population
Where
Hangzhou
Age
18 years and over
People
3,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06775665
Phase 4Enrolling by invitation
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
Where
Hangzhou
Age
18 years to 75 years
People
132
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07103655
No phaseNot yet taking people in China
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
Where
Wenzhou
Age
18 years to 75 years
People
286
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07815301
No phaseNot yet taking people in China
A Real-world HCM-cohort Trial
Where
Xi'an
People
3,000
Run by
Xijing Hospital
See details and how to joinNCT07638033
Phase 2Taking people
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
Where
Beijing, Shanghai, Xinjiang
Age
18 years and over
People
44
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07367724
No phaseTaking people
Valsalva SBP Drop and LVOT Obstruction
Where
Shanghai
Age
18 years and over
People
800
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07483125
Phase 1/2Taking people
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Where
Beijing
Age
18 years to 85 years
People
30
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07464132
No phaseNot yet taking people in China
Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR
Where
Shanghai
Age
18 years and over
People
150
Run by
Shanghai East Hospital
See details and how to joinNCT07294495
No phaseTaking people
REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
Where
Beijing, Hangzhou
Age
18 years to 80 years
People
124
Run by
SuZhou Sinus Medical Technologies Co.,Ltd
See details and how to joinNCT07006493
No phaseTaking people
AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
Where
Hangzhou
Age
18 years and over
People
15,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07263204
Phase 2Taking people
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Where
Beijing
Age
18 years to 85 years
People
300
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07021963
No phaseNot yet taking people in China
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
Where
Shanghai
Age
18 years to 75 years
People
300
Run by
RenJi Hospital
See details and how to joinNCT06794710
No phaseEnrolling by invitation
Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT
Where
Hangzhou
Age
18 years to 70 years
People
200
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT06683872
No phaseTaking people
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
Where
Beijing
Age
18 years and over
People
66
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT05610215
No phaseTaking people
China Structural Ventricular Arrhythmias Registry
Where
Beijing
People
2,000
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT03821051
No phaseTaking people
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Where
Beijing
People
3,000
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT02696135